Search Results - "Pouptsis, Athanasios"
-
1
Surgical and Systemic Treatment of Hereditary Breast Cancer: A Mini-Review With a Focus on BRCA1 and BRCA2 Mutations
Published in Frontiers in oncology (20-10-2020)“…Hereditary breast cancer accounts for 5%-10% of breast cancer cases. The majority of familial cases have been linked to germline mutations in BRCA1 and BRCA2…”
Get full text
Journal Article -
2
Biliary Tract Cancers: Molecular Heterogeneity and New Treatment Options
Published in Cancers (13-11-2020)“…Most patients with biliary tract cancer (BTC) are diagnosed with advanced disease, relapse rates are high in those undergoing surgery and prognosis remains…”
Get full text
Journal Article -
3
Effectiveness of a Computerized Home-Based Cognitive Stimulation Program for Treating Cancer-Related Cognitive Impairment
Published in International journal of environmental research and public health (11-03-2023)“…Cancer patients assert that after chemotherapy their cognitive abilities have deteriorated. Cognitive stimulation is the clinical treatment of choice for…”
Get full text
Journal Article -
4
Metastatic Occult Primary Lobular Breast Cancer: A Case Report
Published in Curēus (Palo Alto, CA) (19-04-2024)“…Breast cancer is the most common malignancy diagnosed in women. Invasive lobular breast cancer (ILC) is the second most common histologic subtype after…”
Get full text
Journal Article -
5
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
Published in Breast cancer research and treatment (01-06-2019)“…Purpose Metastatic breast cancer (mBC) patients with DPYD genetic variants linked to loss of dihydropyrimidine dehydrogenase (DPD) activity are at risk of…”
Get full text
Journal Article -
6
Cardiac safety of neoadjuvant chemotherapy with epirubicin and cyclophosphamide followed by docetaxel/pertuzumab/trastuzumab for HER2-positive breast cancer patients
Published in Journal of B.U.ON. : official journal of the Balkan Union of Oncology (01-05-2021)“…Early-stage, HER2-positive breast cancer is increasingly treated with neoadjuvant chemotherapy (NAC). After the positive results of the Neosphere trial, the…”
Get more information
Journal Article -
7
Efficacy of abiraterone or enzalutamide following docetaxel chemotherapy in the hormone-sensitive setting
Published in Journal of clinical oncology (20-05-2018)“…Abstract only…”
Get full text
Journal Article -
8
Real-world experience of neoadjuvant chemotherapy for early breast cancer patients: an observational non-interventional study in Thessaloniki, Greece
Published in Journal of B.U.ON. : official journal of the Balkan Union of Oncology (01-03-2020)“…Neoadjuvant chemotherapy has been increasingly used in early-stage breast cancer. The results of large randomized clinical trials suggest the need for the…”
Get more information
Journal Article -
9
Primary resistance in docetaxel and androgen deprivation therapy in metastatic castrate sensitive prostate cancer patients
Published in Journal of clinical oncology (20-02-2018)“…Abstract only 342 Background: Docetaxel chemotherapy combined with androgen deprivation therapy (ADT) has become the new standard of care in patients with…”
Get full text
Journal Article -
10
Trifluridine/Tipiracil in Metastatic Colorectal Cancer: A UK Multicenter Real-world Analysis on Efficacy, Safety, Predictive and Prognostic Factors
Published in Clinical colorectal cancer (01-12-2021)“…The orally administered combination trifluridine/tipiracil has been approved as third line treatment in mCRC, demonstrating survival benefit and acceptable…”
Get full text
Journal Article -
11
Real-world experience of trifluridine/tipiracil in patients with metastatic colorectal cancer: A multicenter United Kingdom study
Published in Journal of clinical oncology (01-02-2019)“…Abstract only 668 Background: TAS-102 is an orally administered combination of the thymidine-based nucleic acid analogue, trifluridine and the thymidine…”
Get full text
Journal Article -
12
The potential benefit of trastuzumab-based therapy upon lapatinib progression in heavily preatreated patients with advanced HER2 positive breast cancer
Published in Journal of clinical oncology (20-05-2013)“…Abstract only e11576 Background: Overexpression of human epidermal growth factor receptor 2 (HER2) occurring in about 20% of breast cancers is associated with…”
Get full text
Journal Article -
13
Metastatic Occult Primary Lobular Breast Cancer: A Case Report
Published in Cureus (01-04-2024)“…Breast cancer is the most common malignancy diagnosed in women. Invasive lobular breast cancer (ILC) is the second most common histologic subtype after…”
Get full text
Report